5.59
price down icon5.89%   -0.35
after-market Dopo l'orario di chiusura: 5.59
loading
Precedente Chiudi:
$5.94
Aprire:
$5.72
Volume 24 ore:
59,298
Relative Volume:
0.78
Capitalizzazione di mercato:
$154.25M
Reddito:
$21.25M
Utile/perdita netta:
$-16.05M
Rapporto P/E:
-9.1639
EPS:
-0.61
Flusso di cassa netto:
$-17.14M
1 W Prestazione:
-13.47%
1M Prestazione:
-17.43%
6M Prestazione:
+23.67%
1 anno Prestazione:
-48.10%
Intervallo 1D:
Value
$5.56
$5.89
Intervallo di 1 settimana:
Value
$5.47
$6.50
Portata 52W:
Value
$3.96
$11.15

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Name
Nome
Fennec Pharmaceuticals Inc
Name
Telefono
(919) 636-4530
Name
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Name
Dipendente
0
Name
Cinguettio
@FennecPharma
Name
Prossima data di guadagno
2025-03-10
Name
Ultimi documenti SEC
Name
FENC's Discussions on Twitter

Confronta FENC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FENC
Fennec Pharmaceuticals Inc
5.59 154.25M 21.25M -16.05M -17.14M -0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-11-22 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2022-09-07 Iniziato CapitalOne Overweight
2022-08-08 Ripresa Craig Hallum Buy
2020-06-05 Iniziato Cantor Fitzgerald Overweight
2018-10-11 Iniziato Goldman Buy

Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie

pulisher
Apr 02, 2025

Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average – Should You Sell? - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Apr 01, 2025
pulisher
Mar 27, 2025

(FENC) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 26, 2025

Fennec Pharmaceuticals Achieves Strong Growth and Expands Market Reach in 2024 - TipRanks

Mar 26, 2025
pulisher
Mar 24, 2025

Long Term Trading Analysis for (FRX) (FRX:CA) - news.stocktradersdaily.com

Mar 24, 2025
pulisher
Mar 19, 2025

(FRX) Stock Market Analysis (FRX:CA) - news.stocktradersdaily.com

Mar 19, 2025
pulisher
Mar 16, 2025

(FENC) Technical Data - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 15, 2025

(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com

Mar 15, 2025
pulisher
Mar 14, 2025

Q1 EPS Forecast for Fennec Pharmaceuticals Raised by Analyst - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

HC Wainwright Has Positive Forecast for TSE:FRX Q1 Earnings - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Research Analysts Boost Earnings Estimates for FENC - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

What is HC Wainwright’s Forecast for FENC Q1 Earnings? - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

US$12.60: That's What Analysts Think Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Is Worth After Its Latest Results - Simply Wall St

Mar 13, 2025
pulisher
Mar 13, 2025

Wedbush Boosts Earnings Estimates for Fennec Pharmaceuticals - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Fennec Pharmaceuticals: Strong Growth Potential with PEDMARK’s Market Expansion and Strategic Focus - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Fennec Pharmaceuticals (NASDAQ:FENC) Receives Buy Rating from HC Wainwright - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals Reports Strong Growth Amid Challenges - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals: Strategic Market Expansion and Financial Performance Justify Buy Rating - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

(FRX) Technical Data (FRX:CA) - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 11, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Grows Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals (NASDAQ:FENC) Receives “Outperform” Rating from Wedbush - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals Reports Strong 2024 Sales Growth - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Wedbush Reviews Fennec Pharmaceuticals' Q4 -March 10, 2025 at 12:48 pm EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Reports Strong 2024 Financials and Expands Global Reach - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings Flash (FRX.TO) Fennec Pharmaceuticals Posts Q4 Revenue US$7.925 Million - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings Scheduled For March 10, 2025 - Benzinga

Mar 10, 2025
pulisher
Mar 08, 2025

Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Fennec Pharmaceuticals director Raykov sells $67,900 in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 06, 2025

Fennec Pharmaceuticals director Raykov sells $67,900 in stock - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025 - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Trading (FENC) With Integrated Risk Controls - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 02, 2025

(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily

Mar 02, 2025
pulisher
Feb 24, 2025

Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 18, 2025

Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily

Feb 17, 2025
pulisher
Feb 16, 2025

Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat

Feb 16, 2025

Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):